112 related articles for article (PubMed ID: 27840970)
1. Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma.
Zhu X; Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Liu H; He S
Oncol Rep; 2017 Jan; 37(1):622-630. PubMed ID: 27840970
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
[TBL] [Abstract][Full Text] [Related]
3. Statins as the Controlling Agents for Non-Hodgkin's Lymphomas via Increasing the Casein Kinase 2 Interacting Protein-1: A Hypothesis.
Kazemi K; Mozafari N; Ashrafi H; Rafiei P; Azadi A
Curr Drug Discov Technol; 2020; 17(5):616-618. PubMed ID: 31264550
[TBL] [Abstract][Full Text] [Related]
4. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
[TBL] [Abstract][Full Text] [Related]
5. DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Wang Y; Cheng C
Leuk Res; 2016 Nov; 50():104-111. PubMed ID: 27701018
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
7. Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.
Wu Y; Xu X; Miao X; Zhu X; Yin H; He Y; Li C; Liu Y; Chen Y; Lu X; Wang Y; He S
Cell Prolif; 2015 Dec; 48(6):682-90. PubMed ID: 26478515
[TBL] [Abstract][Full Text] [Related]
8. Expression of small glutamine-rich TPR-containing protein A (SGTA) in Non-Hodgkin's Lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR).
Wang Y; Huang Y; Xu X; Tang J; Huang X; Zhu J; Liu J; Miao X; Wu Y; Yang F; Ji L; He S
Leuk Res; 2014 Aug; 38(8):955-63. PubMed ID: 24974147
[TBL] [Abstract][Full Text] [Related]
9. ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).
Xu X; Wang Q; He Y; Ding L; Zhong F; Ou Y; Shen Y; Liu H; He S
Ann Hematol; 2017 May; 96(5):847-858. PubMed ID: 28238095
[TBL] [Abstract][Full Text] [Related]
10. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance.
He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C
Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405
[TBL] [Abstract][Full Text] [Related]
11. Casein Kinase 2 Interacting Protein-1 Suppresses Glioma Cell Proliferation via Regulating the AKT/GSK3
Xi YG; Ren DP; Jin JY; Zhu L; Yi TL; Shao XF; Sun SK; Zhang WB; Cheng SX
Biomed Res Int; 2019; 2019():5653212. PubMed ID: 31355268
[TBL] [Abstract][Full Text] [Related]
12. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas.
Zhu X; Miao X; Wu Y; Li C; Guo Y; Liu Y; Chen Y; Lu X; Wang Y; He S
Exp Cell Res; 2015 Jul; 335(2):216-23. PubMed ID: 26024773
[TBL] [Abstract][Full Text] [Related]
13. Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas.
He S; Huang Y; Wang Y; Tang J; Song Y; Yu X; Ma J; Wang S; Yin H; Li Q; Ji L; Xu X
Leuk Lymphoma; 2015 Jul; 56(7):2153-61. PubMed ID: 25363345
[TBL] [Abstract][Full Text] [Related]
14. CKIP-1 acts as a colonic tumor suppressor by repressing oncogenic Smurf1 synthesis and promoting Smurf1 autodegradation.
Nie J; Liu L; Xing G; Zhang M; Wei R; Guo M; Li X; Xie P; Li L; He F; Han W; Zhang L
Oncogene; 2014 Jul; 33(28):3677-87. PubMed ID: 23995790
[TBL] [Abstract][Full Text] [Related]
15. [MicroRNA-138 regulates cell adhesion-mediated drug resistance phenotype by targeting SGTA in non-Hodgkin's lymphoma].
Wu YX; He S; Xu XH
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):668-673. PubMed ID: 30180469
[No Abstract] [Full Text] [Related]
16. Casein kinase 2-interacting protein-1, a novel Akt pleckstrin homology domain-interacting protein, down-regulates PI3K/Akt signaling and suppresses tumor growth in vivo.
Tokuda E; Fujita N; Oh-hara T; Sato S; Kurata A; Katayama R; Itoh T; Takenawa T; Miyazono K; Tsuruo T
Cancer Res; 2007 Oct; 67(20):9666-76. PubMed ID: 17942896
[TBL] [Abstract][Full Text] [Related]
17. CKIP-1 regulates macrophage proliferation by inhibiting TRAF6-mediated Akt activation.
Zhang L; Wang Y; Xiao F; Wang S; Xing G; Li Y; Yin X; Lu K; Wei R; Fan J; Chen Y; Li T; Xie P; Yuan L; Song L; Ma L; Ding L; He F; Zhang L
Cell Res; 2014 Jun; 24(6):742-61. PubMed ID: 24777252
[TBL] [Abstract][Full Text] [Related]
18. Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma.
Miao X; Wu Y; Wang Y; Zhu X; Yin H; He Y; Li C; Liu Y; Lu X; Chen Y; Shen R; Xu X; He S
Exp Cell Res; 2016 Aug; 346(2):157-66. PubMed ID: 27397581
[TBL] [Abstract][Full Text] [Related]
19. EphA4 promotes cell proliferation and cell adhesion-mediated drug resistance via the AKT pathway in multiple myeloma.
Ding L; Shen Y; Ni J; Ou Y; Ou Y; Liu H
Tumour Biol; 2017 Mar; 39(3):1010428317694298. PubMed ID: 28351297
[TBL] [Abstract][Full Text] [Related]
20. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
Ma J; Huang H; Han Z; Zhu C; Yue B
Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
